McDonald’s reported pre-bell Q3 adjusted earnings and revenue that outpaced market forecasts.
Pfizer updated its full-year 2024 outlook, projecting adjusted earnings per share of $2.75 to $2.95 and revenues in the range of $61 to $64 billion, buoyed by robust vaccine demand and its oncology busin…
© MarketScreener.com 2024
Pfizer updated its full-year 2024 outlook, projecting adjusted earnings per share of $2.75 to $2.95 and revenues in the range of $61 to $64 billion, buoyed by robust vaccine demand and its oncology busin…
© MarketScreener.com 2024